Literature DB >> 1274972

Particulate matter assessment of a clinical investigation on filtration and infusion phlebitis.

H G Schroeder, P P DeLuca.   

Abstract

Particulate contamination levels of a base intravenous solution and five admixtures were assessed in a double-blind study conducted to determine the effect of inline i.v. filtration on infusion phlebitis. Only a qualitative evaluation on actual patient filters was possible due to deformation of the filter membrane after 72 hours; simulation of i.v. therapy in the laboratory gave more reliable information about particle counts and distribution. The base solution was dextrose 5% in 0.2% sodium chloride injection; the admixtures contained this base solution and the following additives (per liter): (1) 20 mEq potassium chloride, (2) 20 mEq potassium chloride and 2 ml vitamin B complex, (3) 20 mEq potassium chloride and 5 million units of potassium penicillin G, (4) 20 mEq potassium chloride and 1 g cephalothin sodium (delivered in a 100-ml volume from a medication chamber), and (5) 30 mEq potassium chloride and 3 million units of penicillin G (delivered every four hours from a medication chamber) and 80 mg of gentamicin sulfate (delivered every eight hours from a medication chamber). None of the six i.v. infusion schedules simulated exceeded the standards for particulate matter prescribed by the USP XIX. As expected, however, the particle counts increased as a function of the additives used in the simulation, particularly with the antibiotics.

Entities:  

Mesh:

Year:  1976        PMID: 1274972

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  2 in total

1.  Crushed and injected buprenorphine tablets: characteristics of princeps and generic solutions.

Authors:  Régis Bouquié; Laura Wainstein; Paul Pilet; Jean-Marie Mussini; Guillaume Deslandes; Johann Clouet; Eric Dailly; Pascale Jolliet; Caroline Victorri-Vigneau
Journal:  PLoS One       Date:  2014-12-04       Impact factor: 3.240

2.  Frequency and component analysis of contaminants generated in preparation of anticancer agents using closed system drug transfer devices (CSTDs).

Authors:  Satomi Sumikawa; Yoshihiro Yakushijin; Kenjiro Aogi; Takuya Yano; Chiyuki Tsukui; Tadashi Noguchi; Taro Shiraishi; Yasuhiro Horikawa; Yasuo Yasuoka; Akihiro Tanaka; Noriaki Hidaka; Mamoru Tanaka
Journal:  Sci Rep       Date:  2022-01-07       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.